Annovis Bio

Home » Annovis Bio

IPO

Annovis Bio

Pharmaceutical

Annovis is a clinical stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease in Down syndrome (AD-DS), Alzheimer's disease (AD) and Parkinson's disease (PD).

Symbol

ANVS

Price Range
$6.00 - $8.00

Final Shares
1,428,571

Anticipated Date
TBD

Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.

To view the prospectus for Annovis Bio IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253